Minerva Surgical, Inc. UTRS 0.00 Minerva Surgical, Inc.

Home
  /  
Stock List  /  Minerva Surgical, Inc.
Range:0.001-3.4919Vol Avg:0Last Div:0Changes:-0.4
Beta:4.58Cap:0.00BCurrency:USDExchange:NASDAQ
Sector:HealthcareIPO:Fri Oct 22 2021Empoloyees:174
CUSIP:60343F106CIK:0001452965ISIN:SE0000697948Country:US
CEO:Mr. Darrin HammersWebsite:https://minervasurgical.com
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow